Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Bifurcation Lesions Market size was valued at US$ 2,257.5 million in 2023 and is poised to grow at a 5.3% CAGR from 2024 to 2030. A bifurcation lesion refers to constriction of the coronary artery near the origin of a significant side branch. It is caused by the turbulent flow of blood and high shear stress and is also more likely to develop atherosclerotic plaque. It is treated using various techniques such as analysis, X-ray exposure, procedure time, and long-term follow-up. The multi-slice computed tomography and three-dimensional angiography are used in the measurement of bifurcation angles. The availability of treatments specifically designed to treat lesions near coronary bifurcation, along with increasing awareness about the treatment procedures, and an increase in percutaneous coronary intervention operations is expected to drive the growth over the forecast period.
In addition, the increasing number of geriatric patients and the growing demand for minimally invasive procedures are expected to boost the growth. Furthermore, increasing investments in research and development along with the growing medical tourism is expected to further propel the growth. For instance, according to a research study, coronary bifurcation lesions procedure comprises about 20% of total percutaneous coronary interventions. In addition, ongoing clinical trials on stents and balloons for the bifurcation lesions treatment also positively impact the market growth.
However, factors like high treatment costs and reimbursement issues related to bifurcation lesions are expected to hinder the growth of the market. Moreover, the increasing incidence of cardiovascular disease in young age people owing to bad lifestyle choices and increasing endorsement and commercialization of innovative devices for the treatment of bifurcation lesions is expected to provide opportunities for the market players and manufacturers in the growth of the market over the forecast period.
Study Period
2024-2030Base Year
2023CAGR
5.3%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The bifurcation lesions market is expected to grow over the forecasted period due to the increasing prevalence of coronary diseases across the globe. coronary diseases are more prone to geriatric patients and thus growing geriatric patients across the globe is expected to drive the growth. The advanced coronary stenting techniques and devices are developed to improve the bifurcation lesions treatment outcomes. These include techniques such as culotte, T stenting, DK crush techniques. Thus, increasing investments in research and developments in the treatment of bifurcation lesions are expected to further boost the market growth over the forecast period.
The North America bifurcation lesions market is likely to hold a significant revenue share, and in the forecasted years, it is predicted to increase rapidly due to the increasing incidence of coronary artery diseases in this region along with rising investment in the treatment of bifurcation lesions by the market players in this region. Asia Pacific region is expected to have highest CAGR over the forecast period owing to the improvement of healthcare infrastructure and growing medical tourism in countries like India, China, Malaysia in this region.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 2,257.5 million |
|
Market CAGR |
5.3% |
|
By Type |
|
|
By Application |
|
|
By Region |
|
Download Free Sample Report
The global bifurcation lesions market size was valued at US$ 2,257.5 million in 2023 and is projected to grow at a CAGR of 5.3% from 2024-2030.
Increasing prevalence of coronary artery disease along with the increasing number of geriatric patients is expected to drive the growth of bifurcation lesions market.
The leading players in the global bifurcation lesions market are Abbott, Boston Scientific Corporation, Cardinal Health, Medtronic, Johnson & Johnson private ltd, Tecomet, C. R. Bard, Inc, Philips Healthcare, Terumo Medical Corporation, Tryton Medical, Inc., Stryker.
High cost of treatment is expected to restrain the growth of bifurcation lesions market over the forecast period.
| 1.Executive Summary |
| 2.Global Bifurcation Lesions Market Introduction |
| 2.1.Global Bifurcation Lesions Market - Taxonomy |
| 2.2.Global Bifurcation Lesions Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Application |
| 2.2.3.Region |
| 3.Global Bifurcation Lesions Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Bifurcation Lesions Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Bifurcation Lesions Market By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. One Stent |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Two Stent |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Bifurcation Lesions Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Coronary Vascular |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Peripheral Vascular |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Bifurcation Lesions Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Bifurcation Lesions Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.One Stent |
| 8.1.2.Two Stent |
| 8.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Coronary Vascular |
| 8.2.2.Peripheral Vascular |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Bifurcation Lesions Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.One Stent |
| 9.1.2.Two Stent |
| 9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Coronary Vascular |
| 9.2.2.Peripheral Vascular |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Bifurcation Lesions Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.One Stent |
| 10.1.2.Two Stent |
| 10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Coronary Vascular |
| 10.2.2.Peripheral Vascular |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Bifurcation Lesions Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.One Stent |
| 11.1.2.Two Stent |
| 11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Coronary Vascular |
| 11.2.2.Peripheral Vascular |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Bifurcation Lesions Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.One Stent |
| 12.1.2.Two Stent |
| 12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Coronary Vascular |
| 12.2.2.Peripheral Vascular |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Abbott |
| 13.2.2.Boston Scientific Corporation |
| 13.2.3.Cardinal Health |
| 13.2.4.Medtronic |
| 13.2.5.Johnson & Johnson private ltd |
| 13.2.6.Tecomet |
| 13.2.7.C. R. Bard, Inc |
| 13.2.8.Philips Healthcare |
| 13.2.9.Terumo Medical Corporation |
| 13.2.10.Tryton Medical, Inc. |
| 13.2.11.Stryker |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.